{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:09:23Z","timestamp":1790420963461,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG16812"],"award-info":[{"award-number":["IG16812"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG22837"],"award-info":[{"award-number":["IG22837"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor growth and metastatic spreading are heavily affected by the P2X7 receptor as well as microvesicles and exosomes release into the tumor microenvironment. P2X7 receptor stimulation is known to trigger vesicular release from immune and central nervous system cells. However, P2X7 role in microvesicles and exosomes delivery from tumor cells was never analyzed in depth. Here we show that P2X7 is overexpressed in patients affected by metastatic malignant melanoma and that its expression closely correlates with reduced overall survival. Antagonism of melanoma cell-expressed P2X7 receptor inhibited in vitro anchorage-independent growth and migration and in vivo dissemination and lung metastasis formation. P2X7 stimulation triggered the release of miRNA-containing microvesicles and exosomes from melanoma cells, profoundly altering the nature of their miRNA content, as well as their dimensions and quantity. Among the more than 200 miRNAs that we found up-or-down-modulated for each vesicular fraction tested, we identified three miRNAs, miR-495-3p, miR-376c-3p, and miR-6730-3p, that were enriched in both the exosome and microvesicle fraction in a P2X7-dependent fashion. Interestingly, upon transfection, these miRNAs promoted melanoma cell growth or migration, and their vesicular release was minimized by P2X7 antagonism. Our data unveil an exosome\/microvesicle and miRNA-dependent mechanism for the pro-metastatic activity of the P2X7 receptor and highlight this receptor as a suitable prognostic biomarker and therapeutic target in malignant melanoma.<\/jats:p>","DOI":"10.1038\/s41419-021-04378-0","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T04:06:36Z","timestamp":1637121996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Anna","family":"Pegoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"De Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-6887","authenticated-orcid":false,"given":"Manuela","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Orioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-5952","authenticated-orcid":false,"given":"Anna","family":"Tesei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-8059","authenticated-orcid":false,"given":"Marina","family":"Capece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2861","authenticated-orcid":false,"given":"Emi","family":"Dika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Negrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-1362","authenticated-orcid":false,"given":"Francesco","family":"Di Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-9929","authenticated-orcid":false,"given":"Elena","family":"Adinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"4378_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S. The P2X7 receptor in infection and inflammation. Immunity. 2017;47:15\u201331.","journal-title":"Immunity"},{"key":"4378_CR2","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","volume":"72","author":"E Adinolfi","year":"2012","unstructured":"Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, et al. Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res. 2012;72:2957\u201369.","journal-title":"Cancer Res"},{"key":"4378_CR3","doi-asserted-by":"publisher","first-page":"28743","DOI":"10.18632\/oncotarget.4926","volume":"6","author":"A Solini","year":"2015","unstructured":"Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, et al. Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget. 2015;6:28743\u201354.","journal-title":"Oncotarget"},{"key":"4378_CR4","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/onc.2014.444","volume":"34","author":"F Amoroso","year":"2015","unstructured":"Amoroso F, Capece M, Rotondo A, Cangelosi D, Ferracin M, Franceschini A, et al. The P2X7 receptor is a key modulator of the PI3K\/GSK3\u03b2\/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene (Artic). 2015;34:5240\u201351.","journal-title":"Oncogene (Artic)"},{"key":"4378_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.105","volume":"3","author":"F Amoroso","year":"2012","unstructured":"Amoroso F, Falzoni S, Adinolfi E, Ferrari D, Di Virgilio F. The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death Dis. 2012;3:e370.","journal-title":"Cell Death Dis"},{"key":"4378_CR6","doi-asserted-by":"publisher","first-page":"2342.","DOI":"10.3390\/cancers12092342","volume":"12","author":"L Brisson","year":"2020","unstructured":"Brisson L, Chadet S, Lopez-Charcas O, Jelassi B, Ternant D, Chamouton J, et al. P2X7 receptor promotes mouse mammary cancer cell invasiveness and tumour progression, and is a target for anticancer treatment. Cancers. 2020;12:2342.","journal-title":"Cancers"},{"key":"4378_CR7","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/onc.2010.593","volume":"30","author":"B Jelassi","year":"2011","unstructured":"Jelassi B, Chantome A, Alcaraz-Perez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, et al. P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene. 2011;30:2108\u201322.","journal-title":"Oncogene"},{"key":"4378_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/PPO.0000000000000312","volume":"24","author":"JM Hope","year":"2018","unstructured":"Hope JM, Greenlee JD, King MR. Mechanosensitive ion channels: TRPV4 and P2X7 in disseminating cancer cells. Cancer J. 2018;24:84\u201392.","journal-title":"Cancer J"},{"key":"4378_CR9","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/s41388-019-0684-y","volume":"38","author":"E De Marchi","year":"2019","unstructured":"De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A, et al. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene. 2019;38:3636\u201350.","journal-title":"Oncogene"},{"key":"4378_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","volume":"43","author":"D Yang","year":"2015","unstructured":"Yang D, He Y, Munoz-Planillo R, Liu Q, Nunez G. Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015;43:923\u201332.","journal-title":"Immunity"},{"key":"4378_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2019.02.012","volume":"47","author":"E Adinolfi","year":"2019","unstructured":"Adinolfi E, De Marchi E, Orioli E, Pegoraro A, Di Virgilio F. Role of the P2X7 receptor in tumor-associated inflammation. Curr Opin Pharmacol. 2019;47:59\u201364.","journal-title":"Curr Opin Pharmacol"},{"key":"4378_CR12","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","volume":"8","author":"M Lecciso","year":"2017","unstructured":"Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E, et al. ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells. Front Immunol. 2017;8:1918.","journal-title":"Front Immunol"},{"key":"4378_CR13","doi-asserted-by":"publisher","first-page":"e107224","DOI":"10.1371\/journal.pone.0107224","volume":"9","author":"AL Giuliani","year":"2014","unstructured":"Giuliani AL, Colognesi D, Ricco T, Roncato C, Capece M, Amoroso F, et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. PLoS ONE. 2014;9:e107224.","journal-title":"PLoS ONE"},{"key":"4378_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03058-9","volume":"11","author":"A Pegoraro","year":"2020","unstructured":"Pegoraro A, Orioli E, De Marchi E, Salvestrini V, Milani A, Di Virgilio F, et al. Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression. Cell Death Dis. 2020;11:876.","journal-title":"Cell Death Dis"},{"key":"4378_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2012.09.001","volume":"695","author":"F Hattori","year":"2012","unstructured":"Hattori F, Ohshima Y, Seki S, Tsukimoto M, Sato M, Takenouchi T, et al. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7. Eur J Pharm. 2012;695:20\u201326.","journal-title":"Eur J Pharm"},{"key":"4378_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4378_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348.","journal-title":"Cancer Cell"},{"key":"4378_CR18","doi-asserted-by":"publisher","first-page":"20826","DOI":"10.18632\/oncotarget.24846","volume":"9","author":"M Tucci","year":"2018","unstructured":"Tucci M, Mannavola F, Passarelli A, Stucci LS, Cives M, Silvestris F. Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity. Oncotarget. 2018;9:20826\u201337.","journal-title":"Oncotarget"},{"key":"4378_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11523-018-0551-8","volume":"13","author":"M Pucci","year":"2018","unstructured":"Pucci M, Reclusa Asiain P, Durendez Saez E, Jantus-Lewintre E, Malarani M, Khan S, et al. Extracellular vesicles as miRNA nano-shuttles: dual role in tumor progression. Target Oncol. 2018;13:175\u201387.","journal-title":"Target Oncol"},{"key":"4378_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318.","journal-title":"Nat Rev Cancer"},{"key":"4378_CR21","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00280.2019","volume":"318","author":"F Urabe","year":"2020","unstructured":"Urabe F, Kosaka N, Ito K, Kimura T, Egawa S, Ochiya T. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol. 2020;318:C29\u2013C39.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4378_CR22","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1182\/blood-2005-06-031377","volume":"109","author":"C Pizzirani","year":"2007","unstructured":"Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandona D, Savaglio E, et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood. 2007;109:3856\u201364.","journal-title":"Blood"},{"key":"4378_CR23","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1096\/fj.06-7238com","volume":"21","author":"M Baroni","year":"2007","unstructured":"Baroni M, Pizzirani C, Pinotti M, Ferrari D, Adinolfi E, Calzavarini S, et al. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 2007;21:1926\u201333.","journal-title":"FASEB J"},{"key":"4378_CR24","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1002\/eji.201142268","volume":"42","author":"S Gulinelli","year":"2012","unstructured":"Gulinelli S, Salaro E, Vuerich M, Bozzato D, Pizzirani C, Bolognesi G, et al. IL-18 associates to microvesicles shed from human macrophages by a LPS\/TLR-4 independent mechanism in response to P2X receptor stimulation. Eur J Immunol. 2012;42:3334\u201345.","journal-title":"Eur J Immunol"},{"key":"4378_CR25","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.4049\/jimmunol.174.11.7268","volume":"174","author":"F Bianco","year":"2005","unstructured":"Bianco F, Pravettoni E, Colombo A, Schenk U, Moller T, Matteoli M, et al. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol. 2005;174:7268\u201377.","journal-title":"J Immunol"},{"key":"4378_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/emboj.2009.45","volume":"28","author":"F Bianco","year":"2009","unstructured":"Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L, Menna E, et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009;28:1043\u201354.","journal-title":"EMBO J"},{"key":"4378_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3389\/fphar.2020.00793","volume":"11","author":"R Lara","year":"2020","unstructured":"Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, et al. P2X7 in cancer: from molecular mechanisms to therapeutics. Front Pharm. 2020;11:793.","journal-title":"Front Pharm"},{"key":"4378_CR28","doi-asserted-by":"publisher","first-page":"189.","DOI":"10.3390\/cells10010189","volume":"10","author":"A Pegoraro","year":"2021","unstructured":"Pegoraro A, De Marchi E, Adinolfi E. P2X7 variants in oncogenesis. Cells. 2021;10:189.","journal-title":"Cells"},{"key":"4378_CR29","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.7150\/thno.48229","volume":"10","author":"J Benzaquen","year":"2020","unstructured":"Benzaquen J, Dit Hreich SJ, Heeke S, Juhel T, Lalvee S, Bauwens S, et al. P2RX7B is a new theranostic marker for lung adenocarcinoma patients. Theranostics. 2020;10:10849\u201360.","journal-title":"Theranostics"},{"key":"4378_CR30","doi-asserted-by":"publisher","first-page":"202e","DOI":"10.1097\/PRS.0000000000004571","volume":"142","author":"T Knackstedt","year":"2018","unstructured":"Knackstedt T, Knackstedt RW, Couto R, Gastman B. Malignant melanoma: diagnostic and management update. Plast Reconstr Surg. 2018;142:202e\u2013216e.","journal-title":"Plast Reconstr Surg"},{"key":"4378_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2015.09.001","volume":"68","author":"MP Gehring","year":"2015","unstructured":"Gehring MP, Kipper F, Nicoletti NF, Sperotto ND, Zanin R, Tamajusuku AS, et al. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival. Int J Biochem Cell Biol. 2015;68:92\u2013100.","journal-title":"Int J Biochem Cell Biol"},{"key":"4378_CR32","doi-asserted-by":"publisher","first-page":"592442","DOI":"10.3389\/fcell.2020.592442","volume":"8","author":"M Brenet","year":"2020","unstructured":"Brenet M, Martinez S, Perez-Nunez R, Perez LA, Contreras P, Diaz J, et al. Thy-1 (CD90)-Induced metastatic cancer cell migration and invasion are beta3 integrin-dependent and involve a Ca(2+)\/P2X7 receptor signaling axis. Front Cell Dev Biol. 2020;8:592442.","journal-title":"Front Cell Dev Biol"},{"key":"4378_CR33","doi-asserted-by":"publisher","first-page":"617211","DOI":"10.3389\/fphar.2020.617211","volume":"11","author":"S Sharma","year":"2020","unstructured":"Sharma S, Kalra H, Akundi RS. Extracellular ATP mediates cancer cell migration and invasion through increased expression of cyclooxygenase 2. Front Pharm. 2020;11:617211.","journal-title":"Front Pharm"},{"key":"4378_CR34","doi-asserted-by":"crossref","first-page":"e12114","DOI":"10.1002\/jev2.12114","volume":"10","author":"G D\u2019Arrigo","year":"2021","unstructured":"D\u2019Arrigo G, Gabrielli M, Scaroni F, Swuec P, Amin L, Pegoraro A, et al. Astrocytes-derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein. J Extracell Vesicles. 2021;10:e12114.","journal-title":"J Extracell Vesicles"},{"key":"4378_CR35","doi-asserted-by":"publisher","first-page":"654023","DOI":"10.3389\/fphar.2021.654023","volume":"12","author":"M Lombardi","year":"2021","unstructured":"Lombardi M, Gabrielli M, Adinolfi E, Verderio C. Role of ATP in extracellular vesicle biogenesis and dynamics. Front Pharm. 2021;12:654023.","journal-title":"Front Pharm"},{"key":"4378_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-4939-9717-6_13","volume":"2041","author":"E De Marchi","year":"2020","unstructured":"De Marchi E, Orioli E, Pegoraro A, Adinolfi E, Di Virgilio F. Detection of extracellular ATP in the tumor microenvironment, using the pmeLUC biosensor. Methods Mol Biol. 2020;2041:183\u201395.","journal-title":"Methods Mol Biol"},{"key":"4378_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1089\/dna.2013.1977","volume":"32","author":"Y Jin","year":"2013","unstructured":"Jin Y, Peng D, Shen Y, Xu M, Liang Y, Xiao B, et al. MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. DNA Cell Biol. 2013;32:302\u20139.","journal-title":"DNA Cell Biol"},{"key":"4378_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/iep.12177","volume":"97","author":"Y Deng","year":"2016","unstructured":"Deng Y, Xiong Y, Liu Y. miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1. Int J Exp Pathol. 2016;97:257\u201365.","journal-title":"Int J Exp Pathol"},{"key":"4378_CR39","doi-asserted-by":"publisher","first-page":"e0177346","DOI":"10.1371\/journal.pone.0177346","volume":"12","author":"PS Hung","year":"2017","unstructured":"Hung PS, Chen CY, Chen WT, Kuo CY, Fang WL, Huang KH, et al. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLoS ONE. 2017;12:e0177346.","journal-title":"PLoS ONE"},{"key":"4378_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.mie.2019.07.043","volume":"629","author":"F Di Virgilio","year":"2019","unstructured":"Di Virgilio F, Jiang LH, Roger S, Falzoni S, Sarti AC, Vultaggio-Poma V, et al. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells. Methods Enzymol. 2019;629:115\u201350.","journal-title":"Methods Enzymol"},{"key":"4378_CR41","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1096\/fj.09-153601","volume":"24","author":"E Adinolfi","year":"2010","unstructured":"Adinolfi E, Cirillo M, Woltersdorf R, Falzoni S, Chiozzi P, Pellegatti P, et al. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J. 2010;24:3393\u2013404.","journal-title":"FASEB J"},{"key":"4378_CR42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1158\/0008-5472.CAN-14-1259","volume":"75","author":"E Adinolfi","year":"2015","unstructured":"Adinolfi E, Capece M, Franceschini A, Falzoni S, Giuliani AL, Rotondo A, et al. Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res. 2015;75:635\u201344.","journal-title":"Cancer Res"},{"key":"4378_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12015-019-09883-6","volume":"15","author":"M Carluccio","year":"2019","unstructured":"Carluccio M, Zuccarini M, Ziberi S, Giuliani P, Morabito C, Mariggio MA, et al. Involvement of P2X7 receptors in the osteogenic differentiation of mesenchymal stromal\/stem cells derived from human subcutaneous adipose tissue. Stem Cell Rev. 2019;15:574\u201389.","journal-title":"Stem Cell Rev"},{"key":"4378_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"4378_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04378-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T14:29:09Z","timestamp":1699799349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04378-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04378-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FDV is a member of the Scientific Advisory Board of Biosceptre Ltd., a Biotech developing P2X7R-targeted therapies. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1088"}}